翰森制药(03692)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03692 翰森制药

已收盘 03-12 16:08:20

33.520

-0.120

-0.36%

最高34.180	最低33.120	成交量702.91万
今开33.880	昨收33.640	日振幅3.15%
总市值2,030亿	流通市值2,030亿	总股本60.55亿
成交额2.36亿	换手率0.12%	流通股本60.55亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03692","market":"HK","secType":"STK","nameCN":"翰森制药","latestPrice":33.52,"timestamp":1773302900007,"preClose":33.64,"halted":0,"volume":7029070,"delay":0,"changeRate":-0.003567181926278164,"floatShares":6055000000,"shares":6055000000,"eps":0.737226,"marketStatus":"已收盘","change":-0.12,"latestTime":"03-12 16:08:20","open":33.88,"high":34.18,"low":33.12,"amount":236055807,"amplitude":0.03151,"askPrice":33.56,"askSize":2000,"bidPrice":33.52,"bidSize":44000,"shortable":3,"etf":0,"ttmEps":0.87991,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773365400000},"marketStatusCode":5,"adr":0,"listingDate":1560441600000,"exchange":"SEHK","adjPreClose":33.64,"dividendRate":0.010946,"openAndCloseTimeList":[[1773279000000,1773288000000],[1773291600000,1773302400000]],"volumeRatio":0.715365,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03692","defaultTab":"news","newsList":[{"id":"2618513604","title":"每日卖空追踪 | 翰森制药 03月12日卖空量成交65.6万股，卖空比例为9.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618513604","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618513604?lang=zh_cn&edition=full","pubTime":"2026-03-12 16:30","pubTimestamp":1773304236,"startTime":"0","endTime":"0","summary":"翰森制药北京时间03月12日，跌0.36%，卖空量成交65.6万股，较上一交易日减少46.14%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163526a6ba5299&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163526a6ba5299&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03692","BK1583","BK1589","BK1191"],"gpt_icon":0},{"id":"2618902170","title":"世界肾脏日｜警惕“沉默杀手”，药企竞速“护肾”","url":"https://stock-news.laohu8.com/highlight/detail?id=2618902170","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618902170?lang=zh_cn&edition=full","pubTime":"2026-03-12 12:03","pubTimestamp":1773288195,"startTime":"0","endTime":"0","summary":"今年3月12日迎来第21个世界肾脏日，主题为“人人享有肾脏健康：关爱生命，守护地球”，强调个体健康与环境保护的双重关注。更值得警惕的是，CKD起病隐匿，早期常无明显症状，被称为“沉默的杀手”。此外，通过肾脏B超检查，能够观察肾脏形态和结构，排查囊肿、结石等问题。在此背景下，国内外药企加速布局肾病赛道。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312120402a6b9b780&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312120402a6b9b780&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0359202008.SGD","01276","LU1023057109.AUD","03692","LU0359201612.USD","BK1191","LU2543165471.USD","LU0359201885.HKD"],"gpt_icon":0},{"id":"2618094075","title":"翰森制药、恒瑞医药等齐发力，国产GLP-1类减重药加速“破圈”","url":"https://stock-news.laohu8.com/highlight/detail?id=2618094075","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618094075?lang=zh_cn&edition=full","pubTime":"2026-03-11 11:32","pubTimestamp":1773199961,"startTime":"0","endTime":"0","summary":"据悉，在减重药物领域，GLP-1类药物成为热门赛道，国内一批药企也积极抢占这一赛道，并逐渐迎来收获。除了翰森制药外，还有一批国产GLP-1类新药正在加速推进临床。值得一提的是，目前已有多个国产GLP-1类新药获批上市。从临床推进到上市落地，国产GLP-1类药物的多点突破，彰显了我国生物医药产业的自主创新实力。未来，随着药企持续加大研发投入，聚焦剂型创新、适应症拓展，国产GLP-1类药物将在全球肥胖防控领域发挥更重要的作用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031111372197acfd6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031111372197acfd6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1023057109.AUD","BK1191","BK1589","LU2543165471.USD","LU0359201885.HKD","01801","03692","01276","BK1583","LU0359202008.SGD","LU0359201612.USD"],"gpt_icon":0},{"id":"2618920930","title":"胃肠道安全性表现突出，翰森制药奥莱泊肽破解减肥难题","url":"https://stock-news.laohu8.com/highlight/detail?id=2618920930","media":"动脉新医药","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618920930?lang=zh_cn&edition=full","pubTime":"2026-03-11 08:02","pubTimestamp":1773187336,"startTime":"0","endTime":"0","summary":"奥莱泊肽Ⅲ期数据出炉，翰森制药强势入局减重赛道。由此来看，奥莱泊肽有望跻身全球减重药物“第一梯队”。2025年上半年，翰森制药总收入74.34亿元，其中创新药与合作产品销售收入达61.45亿元，占总收入比例上升至82.7%。翰森制药在这一赛道同样获得了国际巨头认可。同时值得关注的是，依托强大的临床转化能力，翰森制药计划于近期在中国递交奥莱泊肽注射液用于长期体重管理的新药上市申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603110816089547a8ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603110816089547a8ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","03692","BK1589","BK1191"],"gpt_icon":0},{"id":"2618940751","title":"减重大战再添中国玩家：翰森奥莱泊肽III期成功，国产GLP-1/GIP双靶点加速入场","url":"https://stock-news.laohu8.com/highlight/detail?id=2618940751","media":"E药经理人","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618940751?lang=zh_cn&edition=full","pubTime":"2026-03-10 21:39","pubTimestamp":1773149950,"startTime":"0","endTime":"0","summary":"中国本土企业在GLP-1双靶点减重药领域正加速追赶全球第一梯队。据悉，奥莱泊肽凭借双靶点协同作用的创新设计，恶心发生率平均不到10%，呕吐发生率平均不到5%。目前，奥莱泊肽计划近期在中国递交新药上市申请，若进展顺利，有望成为中国GLP-1/GIP双靶点前三获批的产品之一。恒瑞医药的HRS9531是GLP-1/GIP双靶点注射剂，减重适应证上市申请已于2025年9月获NMPA受理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310214535a45ec777&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310214535a45ec777&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","01276","LU1023057109.AUD","BK1191","LU2543165471.USD","BK1583","LU0359201612.USD","LU0359201885.HKD","LU0359202008.SGD","03692"],"gpt_icon":0},{"id":"2618560711","title":"翰森制药盘中异动 急速上涨3.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618560711","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618560711?lang=zh_cn&edition=full","pubTime":"2026-03-10 09:48","pubTimestamp":1773107323,"startTime":"0","endTime":"0","summary":"2026年03月10日早盘09时48分，翰森制药股票出现异动，股价大幅上涨3.02%。截至发稿，该股报34.740港元/股，成交量129.436万股，换手率0.02%，振幅3.32%。翰森制药股票所在的药品行业中，整体涨幅为1.12%。其相关个股中，劲方医药-B、开拓药业-B、英硅智能涨幅较大，振幅较大的相关个股有劲方医药-B、长风药业、君圣泰医药-B，振幅分别为28.10%、12.41%、11.32%。翰森制药公司简介：翰森制药集团有限公司是一家主要从事一系列药品的研发、生产及销售的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031009484397ab78d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031009484397ab78d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1589","BK1583","03692"],"gpt_icon":0},{"id":"2618188607","title":"每日卖空追踪 | 翰森制药 03月09日卖空量成交155.6万股，卖空比例为12.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618188607","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618188607?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:30","pubTimestamp":1773045035,"startTime":"0","endTime":"0","summary":"翰森制药北京时间03月09日，涨0.36%，卖空量成交155.6万股，较上一交易日减少32.76%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163506a45ae8ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163506a45ae8ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","03692","BK1191","BK1583"],"gpt_icon":0},{"id":"2618607912","title":"翰森制药宣布奥莱泊肽减重III期注册研究取得积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2618607912","media":"动脉网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618607912?lang=zh_cn&edition=full","pubTime":"2026-03-09 15:33","pubTimestamp":1773041580,"startTime":"0","endTime":"0","summary":"3月7日，翰森制药宣布其首款减重药奥莱泊肽（HS-20094）Ⅲ期注册研究取得积极结果。该研究在中国33个临床中心开展，604例成年受试者参与，旨在评估奥莱泊肽对比安慰剂治疗48周的疗效与安全性。结果显示，奥莱泊肽组体重降幅显著，最高达19.3%，达成5%体重降幅的受试者比例最高达97.2%，且胃肠道耐受性优异，不良事件发生率及停药率更低。研究主要研究者纪立农教授评价其减重疗效显著，胃肠道耐受性优于同类药物，有助于提升治疗依从性。翰森制药董事会执行董事孙远表示，奥莱泊肽有望成为超重及肥胖人群的优质选择。肥胖是复杂慢性病，奥莱泊肽为每周一次皮下注射用GLP-1/GIP受体双激动剂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309154425a45ab182&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309154425a45ab182&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03692","BK1589","BK1583","BK1191"],"gpt_icon":0},{"id":"2618607156","title":"从双雄争霸到群雄突起：巨头重金押注GLP-1，谁更胜一筹？","url":"https://stock-news.laohu8.com/highlight/detail?id=2618607156","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618607156?lang=zh_cn&edition=full","pubTime":"2026-03-09 14:17","pubTimestamp":1773037020,"startTime":"0","endTime":"0","summary":"过去两年间，辉瑞在GLP-1领域的自主研发进程可谓屡遭挫折。2025年4月，辉瑞宣布终止开发口服GLP-1激动剂Danuglipron，原因是在一项剂量优化研究中，1例无症状受试者发生了潜在的药物诱导性肝损伤 。SLIMMER 研究显示，患者在整个48周治疗期间体重持续下降，未出现平台期。据科睿唯安报告，其全球首个靶向GLP-1、GIP、胰高血糖素的三重受体激动剂retatrutide，在肥胖或超重合并膝骨关节炎患者中治疗68周后，平均减重幅度高达28.7% ，达到“手术级减重”水平 。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309142130a6b1599e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309142130a6b1599e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1589","03692","BK1191"],"gpt_icon":0},{"id":"2617576788","title":"翰森制药，阿美替尼新适应症申报上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2617576788","media":"药圈大门","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617576788?lang=zh_cn&edition=full","pubTime":"2026-03-05 18:35","pubTimestamp":1772706916,"startTime":"0","endTime":"0","summary":"3月5日，CDE 官网显示，翰森制药阿美替尼新适应症申报上市。早在2020年3月，阿美替尼就首次获批上市，同年通过谈判进入国家医保目录，目前在国内已经拥有5项获批适应症。基于I期的积极结果，翰森制药在2023年启动了一项III期多中心临床研究，对比达麦利替尼联合阿美替尼与含铂双药化疗的疗效和安全性。阿美替尼作为翰森制药的核心产品之一，此次新适应症的申报如果顺利获批，将进一步扩大其覆盖的患者人群。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305193010a6a685d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305193010a6a685d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03692","BK1583","BK1589","BK1191"],"gpt_icon":0},{"id":"2617762045","title":"每日卖空追踪 | 翰森制药 03月05日卖空量成交94.2万股，卖空比例为9.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617762045","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617762045?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:30","pubTimestamp":1772699436,"startTime":"0","endTime":"0","summary":"翰森制药北京时间03月05日，涨1.56%，卖空量成交94.2万股，较上一交易日减少72.85%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163507a6a5da47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163507a6a5da47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1583","BK1589","03692"],"gpt_icon":0},{"id":"2617576780","title":"翰森制药盘中异动 股价大涨3.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617576780","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617576780?lang=zh_cn&edition=full","pubTime":"2026-03-05 10:10","pubTimestamp":1772676641,"startTime":"0","endTime":"0","summary":"2026年03月05日早盘10时10分，翰森制药股票出现异动，股价大幅上涨3.00%。截至发稿，该股报32.960港元/股，成交量143.116万股，换手率0.02%，振幅2.63%。资金方面，该股资金流入2428.18万港元，流出1386.16万港元。翰森制药股票所在的药品行业中，整体涨幅为1.21%。翰森制药公司简介：翰森制药集团有限公司是一家主要从事一系列药品的研发、生产及销售的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603051010419543110e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603051010419543110e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1589","BK1583","03692"],"gpt_icon":0},{"id":"2616327622","title":"每日卖空追踪 | 翰森制药 03月03日卖空量成交68.8万股，卖空比例为8.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616327622","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616327622?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:30","pubTimestamp":1772526637,"startTime":"0","endTime":"0","summary":"翰森制药北京时间03月03日，跌3.14%，卖空量成交68.8万股，较上一交易日减少70.75%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303163517a69cad42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303163517a69cad42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03692","BK1191","BK1589","BK1583"],"gpt_icon":0},{"id":"2616327982","title":"塔吉瑞创新药TGRX-678启动III期临床：攻克CML耐药“最后防线”，STAMP赛道迎新变局！","url":"https://stock-news.laohu8.com/highlight/detail?id=2616327982","media":"摩熵医药","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616327982?lang=zh_cn&edition=full","pubTime":"2026-03-03 15:34","pubTimestamp":1772523280,"startTime":"0","endTime":"0","summary":"塔吉瑞生物正式启动了其自主研发的TGRX-678片的首个III期临床试验。这意味着，塔吉瑞凭借TGRX-678的III期启动，至少在接下来的一段时间内，将独享“中国STAMP抑制剂领跑者”的光环，并有机会在国产替代与出海竞争中抢占先机。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303153457a69c6608&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303153457a69c6608&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1191","BK1589","06978","03692","BK1161","BK1583"],"gpt_icon":0},{"id":"2616276753","title":"翰森制药盘中异动 股价大跌3.26%报33.240港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616276753","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616276753?lang=zh_cn&edition=full","pubTime":"2026-03-03 10:20","pubTimestamp":1772504418,"startTime":"0","endTime":"0","summary":"2026年03月03日早盘10时20分，翰森制药股票出现异动，股价大幅下挫3.26%。截至发稿，该股报33.240港元/股，成交量188.526万股，换手率0.03%，振幅3.49%。资金方面，该股资金流入3328.7万港元，流出2433.58万港元。翰森制药股票所在的药品行业中，整体跌幅为0.64%。其相关个股中，精优药业、联康生物科技集团、培力农本方涨幅较大，振幅较大的相关个股有宝济药业-B、九源基因、英硅智能，振幅分别为13.59%、10.80%、7.34%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603031020189542b2b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603031020189542b2b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","03692","BK1583","BK1191"],"gpt_icon":0},{"id":"1160311285","title":"翰森制药（03692）2月月报：股本维持不变，无新增发行或回购","url":"https://stock-news.laohu8.com/highlight/detail?id=1160311285","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160311285?lang=zh_cn&edition=full","pubTime":"2026-03-02 17:39","pubTimestamp":1772444360,"startTime":"0","endTime":"0","summary":"翰森制药集团有限公司于2026年3月2日发布截至2026年2月28日的证券变动月报表。报告显示，公司在本报告期内注册股本及已发行股本维持稳定，无新增发行、购回或库存股变动活动。截至2月底，已发行普通股股份总数依旧为6,055,150,070股，库存股份为零，无任何增减变动。公告确认公司现时已符合香港联交所对于最低公众持股量16.21%的相关要求。月报由联席公司秘书钟胜利女士签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692"],"gpt_icon":0},{"id":"2616712807","title":"瑞银：料医疗健康板块收入今年续增长10% 改列三生制药(01530)为首选","url":"https://stock-news.laohu8.com/highlight/detail?id=2616712807","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616712807?lang=zh_cn&edition=full","pubTime":"2026-03-02 13:46","pubTimestamp":1772430360,"startTime":"0","endTime":"0","summary":"瑞银改列三生制药为首选股，取代翰森制药，给予三生制药“买入”评级及目标价41港元，认为其估值合理。展望2026年，该行预测板块收入增长中位数为10%，看好创新药销售增长稳健及研发进展理想。该行并上调多只股份目标价，将石药集团目标价由10港元上调至10.9港元，翰森制药目标价由48.2港元上调至51.5港元，恒瑞医药目标价从96.9港元升至98.3港元，并分别给予“中性”、“买入”及“买入”评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1408878.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BZ08YT58.USD","IE00B543WZ88.USD","LU1226288253.USD","LU1813983027.USD","LU2543165471.USD","LU1152091754.HKD","LU1960683339.HKD","LU0315179316.USD","LU0880133367.SGD","XLV","HK0000165453.HKD","BK1515","IE00B031HY20.USD","IE0008368742.USD","159760","01093","LU1226287792.SGD","IE0008369823.USD","BK1161","IE00B5MMRT66.SGD","LU0140636845.USD","SG9999004220.SGD","LU1023057109.AUD","XBI","LU0314109678.HKD","03692","LU0359201612.USD","BK4588","BK1589","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","LU1226287875.USD","BK1583","LU1226288170.HKD","LU0359201885.HKD","LU1328277881.USD","BK1521","BK4585","LU1226287529.USD","BK1593","LU0326950275.SGD","LU1152091168.USD","01530","01276","LABU","LU1951186391.HKD","BK4581","LU0072913022.USD","LU0501845795.SGD","LU2039709279.SGD"],"gpt_icon":0},{"id":"2616808044","title":"港股开盘受压 恒指低开1.22% 翰森制药(03692)跌3.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616808044","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616808044?lang=zh_cn&edition=full","pubTime":"2026-03-02 09:26","pubTimestamp":1772414819,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股开盘受压，恒指低开1.22%，国企指数低开1%，恒生科技指数低开1.78%。翰森制药跌3.89%，泡泡玛特跌3.39%，汇丰控股跌3.26%，中国人寿跌2.72%，银河娱乐跌2.59%。截至2月28日，公司累计汽车交付量达104.56万辆。百胜中国低开3.14%，公司发布公告，截至2025年12月31日止年度，系统销售额同比增长4%，不计及外币换算影响。截至2025年12月31日，门店总数达18,101家。经营利润率为10.9%，同比增长60个基点。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/YTI1MmE4Njc2MTkyMDEyMA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YTI1MmE4Njc2MTkyMDEyMA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1975670","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00316","BK4588","02833","00386","NIO.SI","601899","BK4585","HHImain","HSBC","PMRTY","ZIJMY","OROVY","BK1589","00027","600938","00857","00005","600028","601628","BK1583","09987","03692","513600","BK1191","02628","MCHmain","YUMC","601857"],"gpt_icon":1},{"id":"2614832325","title":"每日卖空追踪 | 翰森制药 02月27日卖空量成交118.4万股，卖空比例为9.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614832325","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614832325?lang=zh_cn&edition=full","pubTime":"2026-02-27 16:30","pubTimestamp":1772181036,"startTime":"0","endTime":"0","summary":"翰森制药北京时间02月27日，涨2.22%，卖空量成交118.4万股，较上一交易日减少47.8%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227163514a725f4eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227163514a725f4eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1191","03692","BK1589"],"gpt_icon":0},{"id":"2614852088","title":"翰森制药02月27日获主力加仓220.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614852088","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614852088?lang=zh_cn&edition=full","pubTime":"2026-02-27 16:15","pubTimestamp":1772180131,"startTime":"0","endTime":"0","summary":"02月27日, 翰森制药股价涨2.22%，报收34.96元，成交金额4.1亿元，换手率0.20%，振幅3.45%，量比1.62。翰森制药今日主力资金净流入220.7万元，连续5日净流入，上一交易日主力净流入185.2万元。近一年数据显示，该股主力连续5日净流入后，次日上涨概率为46.15%，平均涨幅为2.12%。该股近5个交易日下跌4.74%，主力资金累计净流入2514.8万元；近20日主力资金累计净流入1.3亿元，其中净流入天数为16日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227161720a725e007&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227161720a725e007&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","BK1583","BK1191","03692"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0513},{"period":"1month","weight":-0.0937},{"period":"3month","weight":-0.2242},{"period":"6month","weight":-0.0488},{"period":"1year","weight":0.8094},{"period":"ytd","weight":-0.0676}],"compareEarnings":[{"period":"1week","weight":0.0257},{"period":"1month","weight":-0.0418},{"period":"3month","weight":0.0144},{"period":"6month","weight":-0.0185},{"period":"1year","weight":0.089},{"period":"ytd","weight":0.0105}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"翰森制药集团有限公司是一家主要从事一系列药品的研发、生产及销售的投资控股公司。该公司的创新药产品包括阿美乐、豪森昕福、迈灵达、孚来美、恒沐、昕越、圣罗莱等产品。该公司的创新药产品主要应用于抗肿瘤、抗感染、中枢神经系统（CNS）疾病、代谢及其他治疗领域。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":-0.002565},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.01282},{"month":3,"riseRate":0.285714,"avgChangeRate":0.01585},{"month":4,"riseRate":0.5,"avgChangeRate":0.03201},{"month":5,"riseRate":0.666667,"avgChangeRate":0.019349},{"month":6,"riseRate":0.666667,"avgChangeRate":0.055622},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.000332},{"month":8,"riseRate":0.714286,"avgChangeRate":0.01897},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.033021},{"month":10,"riseRate":0.142857,"avgChangeRate":0.001586},{"month":11,"riseRate":0.714286,"avgChangeRate":0.063467},{"month":12,"riseRate":0.571429,"avgChangeRate":0.016858}],"exchange":"SEHK","name":"翰森制药","nameEN":"HANSOH PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"翰森制药(03692)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供翰森制药(03692)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"翰森制药,03692,翰森制药股票,翰森制药股票老虎,翰森制药股票老虎国际,翰森制药行情,翰森制药股票行情,翰森制药股价,翰森制药股市,翰森制药股票价格,翰森制药股票交易,翰森制药股票购买,翰森制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"翰森制药(03692)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供翰森制药(03692)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}